Background
Methysergide has been as an effective treatment for migraine and cluster headache for over 50 years but has recently been investigated by the European Medicines Agency due to safety concerns.
MethodsTo assess the need for continuing availability of methysergide, the International Headache Society performed an electronic survey among their members.
ResultsThe survey revealed that 71.3% of all respondents had ever prescribed methysergide and 79.8% would prescribe it if it were to become available. Respondents used it more in cluster headache than migraine, and reserved it for use in refractory patients.
ConclusionThe vast majority of headache experts in this survey regarded methysergide a unique treatment option for specific populations for which there are no alternatives, with an urgent need to continue its availability. This position was supported by the International Headache Society.
from Cephalalgia via xlomafota13 on Inoreader http://ift.tt/29XYehO
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου